Featured News

Discover important updates on product innovations, industry insights, and press coverage.

No items found.

No items found.

Latest posts

Stay up to date on our latest news & events.

5 Questions

With Blanca Segura, PhD, CEO & Co-Founder of Triovance

January 17, 2025

Triovance to Present Novel T Treatment for Diabetic Foot Disease and Company Update at Biotech Showcase 2025

Triovance to Present Novel T Treatment for Diabetic Foot Disease and Company Update at Biotech Showcase 2025

TRV-01 is the only technology designed to address the root causes of diabetic foot disease.

December 13, 2024

Triovance Presents Diabetic Foot Disease Treatment to Investors at INCIDE Pharma & Health Tech Booster Program Demo Day

Triovance Presents Diabetic Foot Disease Treatment to Investors at INCIDE Pharma & Health Tech Booster Program Demo Day

Triovance, one of eight private company finalists in the highly competitive.

November 7, 2024

Triovance has been selected for the INCIDE Pharma & Healthtech Booster Program by New Genesis!

Triovance has been selected for the INCIDE Pharma & Healthtech Booster Program by New Genesis!

Triovance has been selected for the INCIDE Pharma & Healthtech Booster Program

September 25, 2024

Triovance Receives Pre-IND Feedback from FDA for its first cellular dressing to treat diabetic foot ulcers

Triovance Receives Pre-IND Feedback from FDA for its first cellular dressing to treat diabetic foot ulcers

Company is on track to move into the clinic with TRV-01, a genetically modified cellular dressing.

October 6, 2023

Triovance presents at 2023 ASGCT Annual Meeting Startup Spotlight

Triovance presents at 2023 ASGCT Annual Meeting Startup Spotlight

Triovance is honored to be presenting at the Startup Spotlight of the 26th American Society of Gene and Cell Therapy

Triovance will present poster at the Symposium on Advanced Wound Care (SAWC Fall) in Las Vegas NV, November 2-5, 2023.

Triovance will present poster at the Symposium on Advanced Wound Care (SAWC Fall) in Las Vegas NV, November 2-5, 2023.

This study evaluated a novel skin graft (TRV-01) developed to improve the wound healing process in a glycated microenvir

Katie Morris, Ph.D
ENTENTE Network
katiemorris@ententeinc.com

Explore our collection of 200+ Premium Webflow Templates